Eligibility Lymphoma NCT00775268

1 Formulários

StudyEvent: Eligibility
1. Eligibility Lymphoma NCT00775268

Name

Tipo

Description | Question | Decode (Coded Value)

Tipo de dados

Alias

Criteria

Item Group

Study Subject Participation Status | Therapeutic procedure Lymphoma | CALGB Clinical Trial Specified | Treatment Course New Lymphoma

Item

participant must be enrolled in a lymphoma therapy study at the nih clinical center or be enrolled in the calgb 50303 study at another site or undergoing a new course of treatment of lymphoma at another facility.

boolean

C2348568 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C0024299 (UMLS CUI [2,2])
C1516238 (UMLS CUI [3,1])
C0008976 (UMLS CUI [3,2])
C0205369 (UMLS CUI [3,3])
C0087111 (UMLS CUI [4,1])
C0750729 (UMLS CUI [4,2])
C0205314 (UMLS CUI [4,3])
C0024299 (UMLS CUI [4,4])

Clinical course Consistent with Lymphoma | Documentation Lymphoma

Item

participants must have a clinical course consistent with lymphoma and have available documentation of lymphoma from either the nci or from an outside pathology laboratory.

boolean

C0449259 (UMLS CUI [1,1])
C0332290 (UMLS CUI [1,2])
C0024299 (UMLS CUI [1,3])
C0920316 (UMLS CUI [2,1])
C0024299 (UMLS CUI [2,2])

Age

Item

participant must be 18 years or older.

boolean

C0001779 (UMLS CUI [1])

ECOG performance status

Item

ecog performance score of 0 or 1.

boolean

C1520224 (UMLS CUI [1])

Informed Consent

Item

ability to provide informed consent. all patients must sign a document of informed consent indicating their understanding of the investigational nature and risks of the study before any protocol related studies are performed.

boolean

C0021430 (UMLS CUI [1])

Enrollment Response Early Arm

Item

for subjects enrolling in early response arm

boolean

C1516879 (UMLS CUI [1,1])
C1704632 (UMLS CUI [1,2])
C1279919 (UMLS CUI [1,3])
C1522541 (UMLS CUI [1,4])

Study Subject Participation Status | CALGB Clinical Trial Specified | Therapeutic procedure Lymphoma | Treatment Course New Lymphoma

Item

must be enrolled in calgb 50303 or a lymphoma therapy study at the nih clinical center or undergoing a new course of treatment of lymphoma at another facility

boolean

C2348568 (UMLS CUI [1])
C1516238 (UMLS CUI [2,1])
C0008976 (UMLS CUI [2,2])
C0205369 (UMLS CUI [2,3])
C0087111 (UMLS CUI [3,1])
C0024299 (UMLS CUI [3,2])
C0087111 (UMLS CUI [4,1])
C0750729 (UMLS CUI [4,2])
C0205314 (UMLS CUI [4,3])
C0024299 (UMLS CUI [4,4])

Absence Therapeutic procedure Lymphoma Current | Absence Therapeutic procedure Recurrent Lymphoma

Item

must not have begun lymphoma therapy for this tumor occurrence/ relapse

boolean

C0332197 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0024299 (UMLS CUI [1,3])
C0521116 (UMLS CUI [1,4])
C0332197 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C4525062 (UMLS CUI [2,3])

Eligibility Independent of Prior Therapy

Item

prior completed therapy does not affect eligibility

boolean

C1548635 (UMLS CUI [1,1])
C0332291 (UMLS CUI [1,2])
C1514463 (UMLS CUI [1,3])

Enrollment Protocol Treatment Arm | Tumor Mass Residual FDG Avidity

Item

for subjects enrolling in the residual fdg avid mass arm

boolean

C1516879 (UMLS CUI [1,1])
C1522541 (UMLS CUI [1,2])
C3273930 (UMLS CUI [2,1])
C1609982 (UMLS CUI [2,2])
C0046056 (UMLS CUI [2,3])
C1510996 (UMLS CUI [2,4])

Tumor Mass Residual Size | FDG-PET Positive

Item

must have a residual fdg pet positive mass greater than equal to 1cm, with uptake greater than that of mediastinal blood pool.

boolean

C3273930 (UMLS CUI [1,1])
C1609982 (UMLS CUI [1,2])
C0456389 (UMLS CUI [1,3])
C3641247 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])

FDG-PET and CT Scan Repeat | FDG-PET Original Inadequate

Item

participant will undergo a repeat fdg pet/ct scan if the original fdg/pet imaging performed at an outside institution is not of adequate imaging quality for subjects enrolling in the residual fdg mass arm.

boolean

C4521453 (UMLS CUI [1,1])
C0205341 (UMLS CUI [1,2])
C3641247 (UMLS CUI [2,1])
C0205313 (UMLS CUI [2,2])
C0205412 (UMLS CUI [2,3])

Exclusion Criteria

Item Group

C0680251 (UMLS CUI)

Hypersensitivity 18F-FLT

Item

known allergy to fluorothymidine.

boolean

C0020517 (UMLS CUI [1,1])
C1432709 (UMLS CUI [1,2])

Delay Standard of Care Scheduled

Item

participants for whom enrollment would significantly delay (greater than 2 weeks) the scheduled standard of care therapy.

boolean

C0205421 (UMLS CUI [1,1])
C2936643 (UMLS CUI [1,2])
C0205539 (UMLS CUI [1,3])

Comorbidity Interferes with Interventional procedure | Mental condition Interferes with Interventional procedure | Comorbidity Interferes with Research results | Mental condition Interferes with Research results

Item

participants with any coexisting medical or psychiatric condition that is likely to interfere with study procedures and/or results are excluded.

boolean

C0009488 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0184661 (UMLS CUI [1,3])
C3840291 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0184661 (UMLS CUI [2,3])
C0009488 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C0683954 (UMLS CUI [3,3])
C3840291 (UMLS CUI [4,1])
C0521102 (UMLS CUI [4,2])
C0683954 (UMLS CUI [4,3])

Claustrophobia Severe | Anti-Anxiety Agents Oral Absent | Body Weight Very high

Item

participants with severe claustrophobia not relieved by oral anxiolytic medication or patients weighing greater than 136 kg (weight limit for scanner table).

boolean

C0008909 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0040616 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C0005910 (UMLS CUI [3,1])
C0442804 (UMLS CUI [3,2])

Other medical condition Ineligibility Interventional procedure

Item

other medical conditions deemed by the pi or associates to make the patient ineligible for protocol procedures.

boolean

C3843040 (UMLS CUI [1,1])
C1512714 (UMLS CUI [1,2])
C0184661 (UMLS CUI [1,3])

Voltar ao início da página

ID

Descrição

Link

Palavras-chave

Versões (1)

Titular dos direitos

Transferido a

DOI

Licença

Comentários do modelo :

Comentários do grupo de itens para :

Comentários do item para :

Eligibility Lymphoma NCT00775268